Real-time enrollment status for this heart disease clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 1:29 PM UTC
| NCT Number | NCT07157774 |
| Recruiting Status | Recruiting |
| Condition | Heart Disease |
| Phase | PHASE3 |
| Target Enrollment | 10,450 participants |
| Active Locations | 159 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | September 24, 2026 (3 weeks ago) |
As of October 16, 2026: Clinical trial NCT07157774 is currently recruiting participants. This phase3 study for heart disease is actively seeking new participants at 159 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07157774 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 159 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07157774 was last updated 3 weeks ago (September 24, 2026). HelloStudys verifies this status automatically.